Results     24-May-23
Announcements
Biocon consolidated net profit rises 31.27% in the March 2023 quarter
Sales rise 56.67% to Rs 3773.90 crore
Net profit of Biocon rose 31.27% to Rs 313.20 crore in the quarter ended March 2023 as against Rs 238.60 crore during the previous quarter ended March 2022. Sales rose 56.67% to Rs 3773.90 crore in the quarter ended March 2023 as against Rs 2408.80 crore during the previous quarter ended March 2022.

For the full year,net profit declined 28.64% to Rs 462.70 crore in the year ended March 2023 as against Rs 648.40 crore during the previous year ended March 2022. Sales rose 36.54% to Rs 11174.20 crore in the year ended March 2023 as against Rs 8184.00 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales3773.902408.80 57 11174.208184.00 37
OPM %25.3622.37 -20.9821.55 -
PBDT863.30595.70 45 2301.601908.40 21
PBT499.60383.50 30 1188.501094.20 9
NP313.20238.60 31 462.70648.40 -29

Previous News
  Biocon Ltd spurts 1.07%, gains for fifth straight session
 ( Hot Pursuit - 03-Jul-25   13:00 )
  Nifty above 25,550 mark; oil & gas shares jump
 ( Market Commentary - Mid-Session 03-Jul-25   10:39 )
  Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars
 ( Hot Pursuit - 03-Jul-25   09:50 )
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
 ( Corporate News - 03-Jul-25   09:12 )
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
Other Stories
  Vasudhagama Enterprises consolidated net profit declines 86.67% in the March 2025 quarter
  30-Jun-25   07:28
  Mahesh Developers reports standalone net profit of Rs 0.05 crore in the March 2025 quarter
  28-Jun-25   07:32
  Maxgrow India reports standalone net loss of Rs 4.52 crore in the March 2025 quarter
  28-Jun-25   07:32
  Rose Merc. reports consolidated net loss of Rs 0.69 crore in the March 2025 quarter
  28-Jun-25   07:32
  NMS Global reports consolidated net profit of Rs 0.21 crore in the March 2025 quarter
  28-Jun-25   07:31
  GCCL Construction & Realities standalone net profit declines 46.67% in the March 2025 quarter
  27-Jun-25   07:34
  Konkan Railway Corporation standalone net profit declines 69.17% in the March 2025 quarter
  27-Jun-25   07:34
  Jorabat Shillong Expressway reports standalone net loss of Rs 10.15 crore in the March 2025 quarter
  27-Jun-25   07:34
  Rare Asset Reconstruction reports standalone net loss of Rs 2.46 crore in the March 2025 quarter
  27-Jun-25   07:34
  Prestige Projects Pvt standalone net profit declines 99.73% in the March 2025 quarter
  27-Jun-25   07:34
Back Top